search
Back to results

Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke (MOONRISE)

Primary Purpose

Stroke Thrombectomy

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
General Anesthesia
Sponsored by
University Hospital Heidelberg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke Thrombectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Decision for thrombectomy according to local protocol for acute recanalizing stroke treatment
  2. Age 18 years or older, either sex
  3. National Institutes of Health Stroke Scale (NIHSS) ≥ 4
  4. Acute ischemic stroke in the posterior circulation with isolated or combined occlusion of vertebral artery (VA) and basilar artery (BA)
  5. Informed consent by the patient him-/herself or his/her legal representative obtainable within 72 h of treatment (deferred consenting procedure)

Exclusion Criteria:

  1. Intracerebral hemorrhage
  2. Coma on admission (Glasgow Coma Scale ≤ 8)
  3. Severe respiratory instability, loss of airway protective reflexes or vomiting on admission, where primary intubation and general anesthesia is deemed necessary
  4. Intubated state before randomization
  5. Severe hemodynamic instability (e.g. due to decompensated cardiac insufficiency)

Sites / Locations

  • Department of Neurology, University Hospital HeidelbergRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

General Anesthesia Group

Procedural Sedation Group

Arm Description

Patients randomized to the GA arm are intubated after anesthetic induction.

After randomization into the PS arm, the need for analgesics or sedatives are evaluated clinically.

Outcomes

Primary Outcome Measures

Functional outcome as measured by modified Ranking Scale (mRS) after admission.
0-6; higher mean worse outcome

Secondary Outcome Measures

Early neurological improvement indicated by change of National Institute of Health Stroke Scale (NIHSS) Score 24 hours after admission
0-42 points; higher mean worse outcome
Mortality
cerebral or non-cerebral cause of death
Postinterventional pc-ASPECTS, determined with CT or MRI post-interventional follow up scan
semi-quantitative method for grading irreversible ischemia in the vertebrobasilar system; 0-10 points; lower mean higher infarct volumes
Feasibility of EST
e.g. necessity of intubation, cardio-respiratory stability, loss in level of consciousness, loss of cough reflex, vomiting
Complications before/during and after EST
e.g. severe agitation, loss of level of consciousness, loss of cough reflex, vomiting, cardio-respiratory stability

Full Information

First Posted
August 23, 2022
Last Updated
October 11, 2022
Sponsor
University Hospital Heidelberg
search

1. Study Identification

Unique Protocol Identification Number
NCT05525325
Brief Title
Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke
Acronym
MOONRISE
Official Title
Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2022 (Actual)
Primary Completion Date
October 2026 (Anticipated)
Study Completion Date
January 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital Heidelberg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Optimal anesthetic mode is not established for patients with vertebrobasilar stroke undergoing endovascular treatment. We want to investigate whether a procedural sedation mode approach is feasible compared to general anesthesia
Detailed Description
Endovascular treatment has become standard of care for many patients with acute ischemic strokes due to large vessel occlusions and is recommended by several national and international guidelines. Several studies have shown that anesthetic modality during endovascular treatment might affect the functional outcome. While much evidence has been generated for ischemic stroke of the anterior circulation, only a few studies have investigated anesthetic modalities in strokes with occlusions of the vertebrobasilar arteries. The majority of patients with vertebrobasilar occlusion strokes undergo endovascular procedure in general anesthesia and not a less burdensome sedation despite the lack of evidence for that approach. A few retrospective studies and a small single-center prospective randomized trial investigating this topic indicate that primary procedural sedation might be a feasible anesthetic approach. Here we aim to provide further high-level evidence by conducting a prospective randomized clinical trial with a PROBE (parallel-group, open-label randomized controlled with blinded endpoint evaluation) design for this research question.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke Thrombectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
128 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
General Anesthesia Group
Arm Type
Active Comparator
Arm Description
Patients randomized to the GA arm are intubated after anesthetic induction.
Arm Title
Procedural Sedation Group
Arm Type
Experimental
Arm Description
After randomization into the PS arm, the need for analgesics or sedatives are evaluated clinically.
Intervention Type
Procedure
Intervention Name(s)
General Anesthesia
Intervention Description
Patients randomized to the GA arm are intubated after anesthetic induction. For this purpose, they are pre-oxygenated with an oxygen mask and non-invasive monitoring is established. After sufficient pre-oxygenation has been applied, analgesic and sedative medication are administered. If the patient is sufficiently long nil by mouth they are manually ventilated before a muscle relaxant is administered. A rapid-sequence induction is performed with administration of an opioid, sedative and muscle relaxant in rapid succession and without intermediate manual ventilation in non-nil by mouth patients. To secure the airway, an endotracheal tube is inserted into the trachea with the aid of a laryngoscope. After insertion of the endotracheal tube, its endotracheal position is confirmed with auscultation and capnography. GA maintenance therapy with opioids, sedatives and catecholamines, if needed, will then be started.
Primary Outcome Measure Information:
Title
Functional outcome as measured by modified Ranking Scale (mRS) after admission.
Description
0-6; higher mean worse outcome
Time Frame
90 days +/- 2 weeks
Secondary Outcome Measure Information:
Title
Early neurological improvement indicated by change of National Institute of Health Stroke Scale (NIHSS) Score 24 hours after admission
Description
0-42 points; higher mean worse outcome
Time Frame
[NIHSS on admission - NIHSS after 24 hours]
Title
Mortality
Description
cerebral or non-cerebral cause of death
Time Frame
intra-hospital until discharge up to 2 weeks [yes/no] and over the whole follow-up period up to 3 months [time to event]
Title
Postinterventional pc-ASPECTS, determined with CT or MRI post-interventional follow up scan
Description
semi-quantitative method for grading irreversible ischemia in the vertebrobasilar system; 0-10 points; lower mean higher infarct volumes
Time Frame
12-36 hours after admission
Title
Feasibility of EST
Description
e.g. necessity of intubation, cardio-respiratory stability, loss in level of consciousness, loss of cough reflex, vomiting
Time Frame
duration of thrombectomy procedure in minutes
Title
Complications before/during and after EST
Description
e.g. severe agitation, loss of level of consciousness, loss of cough reflex, vomiting, cardio-respiratory stability
Time Frame
duration of the whole hospital stay in days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Decision for thrombectomy according to local protocol for acute recanalizing stroke treatment Age 18 years or older, either sex National Institutes of Health Stroke Scale (NIHSS) ≥ 4 Acute ischemic stroke in the posterior circulation with isolated or combined occlusion of vertebral artery (VA) and basilar artery (BA) Informed consent by the patient him-/herself or his/her legal representative obtainable within 72 h of treatment (deferred consenting procedure) Exclusion Criteria: Intracerebral hemorrhage Coma on admission (Glasgow Coma Scale ≤ 8) Severe respiratory instability, loss of airway protective reflexes or vomiting on admission, where primary intubation and general anesthesia is deemed necessary Intubated state before randomization Severe hemodynamic instability (e.g. due to decompensated cardiac insufficiency)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Min Chen, MD
Phone
0049/6221/7504
Email
min.chen@med.uni-heidelberg.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Silvia Schönenberger, MD
Organizational Affiliation
University Hospital Heidelberg
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Min Chen, MD
Organizational Affiliation
UUHeidelberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neurology, University Hospital Heidelberg
City
Heidelberg
State/Province
Baden-Württemberg
ZIP/Postal Code
69120
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Silvia Schönenberger, Dr.
Phone
0049-6221-5637549
Email
silvia.schoenenberger@med.uni-heidelberg.de
First Name & Middle Initial & Last Name & Degree
Silvia Schönenberger, Dr.

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28395002
Citation
Jadhav AP, Bouslama M, Aghaebrahim A, Rebello LC, Starr MT, Haussen DC, Ranginani M, Whalin MK, Jovin TG, Nogueira RG. Monitored Anesthesia Care vs Intubation for Vertebrobasilar Stroke Endovascular Therapy. JAMA Neurol. 2017 Jun 1;74(6):704-709. doi: 10.1001/jamaneurol.2017.0192.
Results Reference
background
PubMed Identifier
34603184
Citation
Weyland CS, Chen M, Potreck A, Jager LB, Seker F, Schonenberger S, Bendszus M, Mohlenbruch M. Sedation Mode During Endovascular Stroke Treatment in the Posterior Circulation-Is Conscious Sedation for Eligible Patients Feasible? Front Neurol. 2021 Sep 17;12:711558. doi: 10.3389/fneur.2021.711558. eCollection 2021.
Results Reference
background
PubMed Identifier
31573636
Citation
Schonenberger S, Henden PL, Simonsen CZ, Uhlmann L, Klose C, Pfaff JAR, Yoo AJ, Sorensen LH, Ringleb PA, Wick W, Kieser M, Mohlenbruch MA, Rasmussen M, Rentzos A, Bosel J. Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis. JAMA. 2019 Oct 1;322(13):1283-1293. doi: 10.1001/jama.2019.11455. Erratum In: JAMA. 2019 Dec 24;322(24):2445.
Results Reference
result

Learn more about this trial

Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke

We'll reach out to this number within 24 hrs